Neonatal Vancomycin Extended Interval Dosing

Calculate neonatal vancomycin extended-interval dosing based on gestational age, postnatal age, and weight, using maturation-based pharmacokinetic parameters to achieve therapeutic AUC targets in NICU patients.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Calculate neonatal vancomycin extended-interval dosing based on gestational age, postnatal age, and weight, using maturation-based pharmacokinetic parameters to achieve therapeutic AUC targets in NICU patients

Each component has a specific meaning:

  • Gestational age — The gestational age recorded for the scenario being assessed.
  • Postnatal age — The postnatal age recorded for the scenario being assessed.
  • Weight — The weight recorded for the scenario being assessed.

Note: Interpret the neonatal vancomycin result against the thresholds and context described above.

How to Use

Enter the gestational age, postnatal age, weight for the scenario you are assessing. Calculate neonatal vancomycin extended-interval dosing based on gestational age, postnatal age, and weight, using maturation-based pharmacokinetic parameters to achieve therapeutic AUC targets in NICU patients. Use the neonatal vancomycin result to inform your calculation.

Frequently Asked Questions